No local entity
Run a clinical trial in Australia without setting up a local entity
Overseas companies can conduct clinical trials in Australia, but the Australian trial still needs an Australian sponsor entity.
If the only immediate reason to set up an Australian subsidiary is to hold the sponsor role, appointing a local sponsor may be a cleaner route.
Short answer
An overseas company can run an Australian clinical trial without setting up its own Australian entity by appointing an Australian local sponsor such as Clintrail to hold the sponsor role for the Australian clinical trial.
Commercial issue
A local company can be expensive infrastructure for one trial.
Creating a local entity can bring incorporation, directors, governance, accounting, tax, banking, administration, and ongoing maintenance. That may be disproportionate if the company only needs an Australian sponsor for a defined clinical trial.
For many overseas teams, the better first question is whether local sponsorship can support the Australian clinical trial while the global sponsor model remains in place.
Sponsor solution
Clintrail holds the Australian sponsor role.
Clintrail can act as the Australian local sponsor, allowing the overseas company to continue owning the product, protocol strategy, global program, funding decisions, and broader development plan.
The work is not just naming an Australian entity. The parties need to document the responsibility split before startup so the Australian sponsor role is operationally credible.
Best fit
When this structure usually makes sense.
This approach is often relevant where the sponsor is testing Australia for a first study, adding Australian sites to a broader global program, or running early clinical work before committing to a larger Australian footprint.
- First Australian clinical trial.
- Pilot, feasibility, early-stage, or limited-scope Australian activity.
- Global trial adding Australian sites.
- Medical device, IVD, diagnostics, biotech, or pharma program without an Australian subsidiary.
- A need to move sponsor structure forward without building corporate infrastructure too early.
Common questions
Questions overseas teams usually ask
Does this avoid all Australian setup work?
No. The trial still needs the right approvals, contracts, insurance and indemnity arrangements, site governance, safety reporting, records, and operational setup. Local sponsorship addresses the sponsor entity requirement.
Do we lose control of the product or program?
No. The overseas company keeps product ownership, IP, global strategy, funding, and broader program leadership while Clintrail holds the Australian sponsor role for the local clinical trial.
Is this only for early-stage companies?
No. It can also be useful for established companies adding Australia to a global program where forming an Australian entity is not commercially justified for the trial scope.
Source context
Grounded in Australian clinical trial requirements.
These pages are written for planning clarity. They do not replace legal, tax, regulatory, insurance, ethics, or clinical operations advice for a specific trial.
Related pages
Continue the sponsor-structure research
CTN vs CTA in Australia for overseas sponsors
A practical guide for overseas sponsors comparing Australia's CTN and CTA pathways and understanding where the Australian local sponsor fits.
Australian clinical trial sponsor responsibilities
What overseas sponsors need to understand about the Australian clinical trial sponsor role, sponsor oversight, approvals, safety, records, and responsibility allocation.
Medical device trials in Australia with a local sponsor
How overseas medical device companies can use an Australian local sponsor for Australian clinical trials, including device-specific sponsor considerations.
IVD and diagnostics trials in Australia with a local sponsor
How overseas diagnostics and IVD companies can structure Australian clinical performance or diagnostics studies with an Australian local sponsor.
Next step
Need an Australian local sponsor?
Send through a short description of the clinical trial and your planned Australian activity. We will review it and get back to you soon.